Interview with Ioannis Papanikolaou, MD, PhD, FEBGH. (“Attikon” University General Hospital, National and Kapodistrian University of Athens).

DIOPTRA Interviews: A Clinical perspective from the field

We recently reached out to some of the DIOPTRA partners who are leading various activities to gain their perspectives on the project’s mission from their areas of expertise. This resulted in a series of video interviews that will be available on our website and official YouTube channel, where they share insights into their challenges and…

Colorectal

CRC Awareness Month: Shining a Spotlight on Early Detection and Prevention

Colorectal cancer (CRC) is a significant global health concern, with more than 500,000 European citizens diagnosed every year. As we observe Colorectal Cancer Awareness Month this March, it’s crucial to shine a spotlight on the importance of early detection and prevention strategies in combating this disease. At DIOPTRA, our mission is to revolutionize CRC screening by…

CSCY's booth at the Innovent Forum 2024

A Spotlight on Personalized Medicine: DIOPTRA participates at Innovent Forum

In the bustling city of Larissa, Greece, the 2024 Innovent Forum stirred excitement and anticipation among innovators, researchers, and industry leaders alike. Among the myriad of groundbreaking discussions and presentations, one stood out prominently – the discourse on personalised medicine and its intersection with medical informatics. At the forefront of this dialogue was Stavros Pitoglou…

Presentation of the DIOPTRA project, with a particular focus on the DIOPTRA application for behavior monitoring and change in relation to CRC risk factors

DIOPTRA Contributes to  E-Health4Cancer Event for CRC Solutions

DIOPTRA participated in the Symposium on E-health Solutions for Cancer Patients and Their Caregivers last month. The event provided an essential opportunity for DIOPTRA to present the Horizon Europe project, which aims to provide groundbreaking new technologies to address colorectal cancer (CRC) risk assessment, screening, and progression.  The event, which ran from January 10 to…

DIOPTRA launches ambitious new study

Groundbreaking study aims to improve detection of colorectal cancer using AI technology

DIOPTRA project is thrilled to announce the launch of an ambitious new study designed to make early detection of colorectal cancer (CRC) more accessible and effective. The study will combine artificial intelligence (AI) and blood tests to identify the disease at its earliest stages, offering hope for more effective treatment and potentially saving lives. The…

Second DIOPTRA consortium meeting concludes with key actions for advancing Colorectal Cancer research

Second DIOPTRA consortium meeting concludes with key actions for advancing Colorectal Cancer research

The second plenary meeting of the DIOPTRA consortium took place on October 2nd and 3rd in Nicosia, Cyprus, hosted by the Institute of Communication & Computer Systems (ICCS). This important meeting charted the course for the upcoming phases of our project that aims to revolutionise colorectal cancer (CRC) screening and diagnostics through advanced technology. The…

Predictive Risk Factors for Colorectal Cancer

DIOPTRA study launched to identify Colorectal Cancer risk factors using AI

The ‘Predictive Risk Factors for Colorectal Cancer in the DIOPTRA Retrospective Study’ is a groundbreaking research endeavour aimed at understanding the variables strongly correlated with Colorectal Cancer (CRC). Spanning 34 months and involving over 5000 subjects, the study aims to identify early CRC risk through the meticulous analysis of data, employing both statistical methods and…